Warrant
Issued 2026
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Medicinal Chemicals & Botanical ProductsIndustry: Drug Manufacturers - Specialty & GenericCountry: CAExchange: Nasdaq
DilutionScan read 41 of Canopy Growth Corp's SEC filings and found 9 warrant series, 3 convertibles, 3 ATM programs, 3 shelf registrations and 3 completed offerings on file for CGC. The latest dilution event on file is ATM sales on Aug 5, 2026. Analysis updated Oct 31, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 90 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 5, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2025
Total capacity
Sold to date
Issued 2025
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Drug Manufacturers - Specialty & Generic. All tickers A to Z